USFDA postpones Organon’s eczema drug review by three months
The US regulator has extended a review of an application by Organon & Co.’s atopic dermatitis (eczema) drug by three months with a.
Drugs
Health
Pharma
Climate
Health
Medical
Babies inhale air pollutants in the womb, study
Exposure to carbon particles can lead to lung and brain damage in foetuses in the first trimester